P
Philip D. Harvey
Researcher at University of Miami
Publications - 725
Citations - 39464
Philip D. Harvey is an academic researcher from University of Miami. The author has contributed to research in topics: Schizophrenia & Cognition. The author has an hindex of 97, co-authored 654 publications receiving 34893 citations. Previous affiliations of Philip D. Harvey include United States Department of Veterans Affairs & Binghamton University.
Papers
More filters
Journal ArticleDOI
The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery.
Richard S.E. Keefe,Terry E. Goldberg,Philip D. Harvey,James M. Gold,Margaret P. Poe,Leigh Coughenour +5 more
TL;DR: The BACS was found to be as sensitive to cognitive impairment in patients with schizophrenia as a standard battery of tests that required over 2 h to administer and to be highly correlated with the standard battery composite scores in patients and healthy controls.
Journal ArticleDOI
Neurocognitive Effects of Antipsychotic Medications in Patients With Chronic Schizophrenia in the CATIE Trial
Richard S.E. Keefe,Robert M. Bilder,Sonia M. Davis,Philip D. Harvey,Barton W. Palmer,James M. Gold,Herbert Y. Meltzer,Michael F. Green,George Capuano,T. Scott Stroup,Joseph P. McEvoy,Marvin S. Swartz,Robert A. Rosenheck,Diana O. Perkins,Clarence E. Davis,John K. Hsiao,Jeffrey A. Lieberman +16 more
TL;DR: After 2 months of antipsychotic treatment, all groups had a small but significant improvement in neurocognition, and after 18 months of treatment, neurocognitive improvement was greater in the perphenazine group than in the olanzapine and risperidone groups.
Journal ArticleDOI
Administration and interpretation of the Trail Making Test.
TL;DR: The Trail Making Test is an accessible neuropsychological instrument that provides the examiner with information on a wide range of cognitive skills and can be completed in 5–10 min.
Journal ArticleDOI
White matter changes in schizophrenia: evidence for myelin-related dysfunction.
Kenneth L. Davis,Daniel G. Stewart,Joseph I. Friedman,Monte S. Buchsbaum,Philip D. Harvey,Patrick R. Hof,Joseph D. Buxbaum,Vahram Haroutunian +7 more
TL;DR: Support for the hypothesis that oligodendroglial dysfunction and even death, with subsequent abnormalities in myelin maintenance and repair, contribute to the schizophrenic syndrome is supported.
Journal ArticleDOI
Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms.
Christopher R. Bowie,Abraham Reichenberg,Thomas L. Patterson,Robert K. Heaton,Philip D. Harvey +4 more
TL;DR: In this paper, the authors examined cross-sectional data from a study of the course of neuropsychological and adaptive life skills of older (age 50-85) schizophrenia patients (N=78).